NL
DE
The Hematology-Lymphoma Biobank plans to collect blood, saliva, serum and cell-free DNA from every lymphoma patient, in addition to the residual material available from the Pathology department (tumor tissue), the Hematology department and the Laboratory of Hematology (bone marrow, peripheral blood and tumor tissue). In recent years, much progress has been made in the knowledge surrounding the processes involved in the development and progression of lymph node cancer and the response to therapy. The aim and ambition of HEMLYM is to improve the diagnosis and treatment of patients with lymphoma.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
New business model for the Radboud Biobank
24 November 2024The Radboudumc Board of Directors decided, after receiving advice from the UMC council, to change the Radboud Biobank business model.
read more
Planning requests for samples
24 November 2024To avoid disappointment when requesting samples in peak periods, we strongly advise waiting for the Radboud Biobank planning before scheduling laboratory tests and analyses.
read more
National Biobanks & Collections Day 2025
24 November 2024The second edition of the Biobanks & Collection Day will take place on 27th of March in the Auditorium at Radboudumc in Nijmegen.
read more
Development of a new Dutch biobank standard
24 November 2024In 2023, within the framework of Health-RI Theme Biobanks & Collections, a team of biobankers initiated the development of a novel Dutch biobanking standard.
read more
Introducing Wesley van Bronckhorst
24 November 2024My name is Wesley van Bronckhorst, and I recently started as an analyst at the Radboud Biobank.
read moreNational Biobanks & Collections day
19 October 2023The Health-RI Biobanks & Collections workgroup proudly announces the first National Biobanks & Collections Day. The meeting will take place on November 9 in Amsterdam.
read more